Cause of Death Changed the Comparison in Postmortem CB1 Research
Postmortem CB1 findings in alcohol-dependent people differed according to whether death involved suicide. Combining those groups could obscure a meaningful feature of the research comparison.
The review described a subgroup difference
Pava and Woodward report increased CB1 expression in specified brain regions among alcohol-dependent people who died by suicide compared with alcohol-dependent people who died from other causes. The evidence came from postmortem tissue.
The result does not establish direction or prediction
A measurement obtained after death cannot by itself show whether the difference preceded the illness, reflected its course or related to other characteristics of the groups. An association also does not establish that CB1 expression caused suicide.
A proposed biomarker needs a different validation design
The reviewers identify altered endocannabinoid function as a possible biomarker research direction. That proposal is separate from demonstrating useful prospective prediction in living people. The postmortem comparison should retain cause-of-death grouping, sampled region and measured outcome. It is neither a cannabis-exposure finding nor a validated assessment of an individual’s future risk. Its methodological value is to show why sampling and subgroup definitions matter before generalizing a tissue result.
Related reading: Alcohol–Endocannabinoid Reviews Need to Keep Stages of Dependence Separate.
Research cited
Pava MJ, Woodward JJ. A Review of the Interactions between Alcohol and the Endocannabinoid System: Implications for Alcohol Dependence and Future Directions for Research (2012). The experiments discussed here are described through this supplied review.
